Meeting
2020 ASCO Virtual Scientific Program
Perioperative FLOT in elderly patients with resectable gastric cancer: Subgroup analysis from the observational RealFLOT study.
Authors
Elisa Giommoni
Medical Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
Elisa Giommoni , Ferdinando De Vita , Irene Pecora , Francesco Iachetta , Antonia Strippoli , Maria Antonietta Satolli , Andrea Spallanzani , Marco Puzzoni , Floriana Nappo , Michele Sisani , Vincenzo Formica , Filippo Giovanardi , Carmelo Pozzo , Michele Prisciandaro , Samantha Di Donato , Luca Pompella , Francesca Salani , Giuseppe Tirino , Daniele Lavacchi , Lorenzo Antonuzzo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4548)
DOI
10.1200/JCO.2020.38.15_suppl.4548
Abstract #
4548
Poster Bd #
156
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Perioperative FLOT in resectable gastric cancer: Italian real-world data from the RealFLOT study.
First Author: Elisa Giommoni
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor regression grade after neoadjuvant chemotherapy in patients with locally advanced gastric cancer treated with modern chemotherapy (FLOT): Experience in patients in Guatemala.
First Author: Rixci Ramirez
Poster
2023 ASCO Breakthrough
Immunonutrition supplementation for resectable gastric cancer during standard perioperative chemotherapy (CT) FLOT: A pivotal study, I–SUPPLY.
First Author: Valeria Pusceddu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
First Author: Yuri Yoshinami